HLA-E and neoplasm: However, the expression of the NK cell inhibitory ligand HLA-E exhibited the opposite pattern, with lower expression in MDA-MB-231 tumor tissue than in RT-R-MDA-MB-231 or CD24−/low/CD44+ tumor tissue (Figure 7C).